Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples